U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C26H28N6O.C4H6O4
Molecular Weight 999.1683
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NEMIRALISIB SUCCINATE

SMILES

OC(=O)CCC(O)=O.CC(C)N1CCN(CC2=CN=C(O2)C3=CC(=CC4=C3C=NN4)C5=CC=CC6=C5C=CN6)CC1.CC(C)N7CCN(CC8=CN=C(O8)C9=CC(=CC%10=C9C=NN%10)C%11=CC=CC%12=C%11C=CN%12)CC7

InChI

InChIKey=MEBXGOVBBDIMBC-UHFFFAOYSA-N
InChI=1S/2C26H28N6O.C4H6O4/c2*1-17(2)32-10-8-31(9-11-32)16-19-14-28-26(33-19)22-12-18(13-25-23(22)15-29-30-25)20-4-3-5-24-21(20)6-7-27-24;5-3(6)1-2-4(7)8/h2*3-7,12-15,17,27H,8-11,16H2,1-2H3,(H,29,30);1-2H2,(H,5,6)(H,7,8)

HIDE SMILES / InChI

Molecular Formula C4H6O4
Molecular Weight 118.088
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C26H28N6O
Molecular Weight 440.5401
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

GSK-2269557 (nemiralisib), a PI3Kδ inhibitor, is in development as an anti-inflammatory drug for the treatment of inflammatory airways disease. Studies in moderate or severe stable COPD patients have shown an acceptable safety and tolerability profile when GSK-2269557 was administered via inhalation. Cough was the most commonly reported adverse event.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
9.9 null [pKi]
Substance Class Chemical
Created
by admin
on Sat Dec 16 10:47:53 UTC 2023
Edited
by admin
on Sat Dec 16 10:47:53 UTC 2023
Record UNII
K01RTI0V6O
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
NEMIRALISIB SUCCINATE
USAN  
USAN  
Official Name English
BUTANEDIOIC ACID, COMPD. WITH 6-(1H-INDOL-4-YL)-4-(5-((4-(1-METHYLETHYL)-1-PIPERAZINYL)METHYL)-2-OXAZOLYL)-1H-INDAZOLE (1:2)
Common Name English
NEMIRALISIB SUCCINATE [USAN]
Common Name English
GSK2269557H
Code English
Bis[6-(1H-indol-4-yl)-4-(5-{[4-(propan-2-yl)piperazin-1-yl]methyl}-1,3-oxazol-5-yl)-1H-indazole] butanedioate
Systematic Name English
GSK-2269557H
Code English
NEMIRALISIB HEMISUCCINATE
Common Name English
Code System Code Type Description
CAS
1364799-98-3
Created by admin on Sat Dec 16 10:47:53 UTC 2023 , Edited by admin on Sat Dec 16 10:47:53 UTC 2023
PRIMARY
PUBCHEM
124220583
Created by admin on Sat Dec 16 10:47:53 UTC 2023 , Edited by admin on Sat Dec 16 10:47:53 UTC 2023
PRIMARY
USAN
EF-41
Created by admin on Sat Dec 16 10:47:53 UTC 2023 , Edited by admin on Sat Dec 16 10:47:53 UTC 2023
PRIMARY
NCI_THESAURUS
C170210
Created by admin on Sat Dec 16 10:47:53 UTC 2023 , Edited by admin on Sat Dec 16 10:47:53 UTC 2023
PRIMARY
FDA UNII
K01RTI0V6O
Created by admin on Sat Dec 16 10:47:53 UTC 2023 , Edited by admin on Sat Dec 16 10:47:53 UTC 2023
PRIMARY
SMS_ID
100000175666
Created by admin on Sat Dec 16 10:47:53 UTC 2023 , Edited by admin on Sat Dec 16 10:47:53 UTC 2023
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY